Ovarian Cancer

Ovarian Cancer News


Ovarian Cancer Perspective

  • Oncologists' Off-Label Prescribing Pits Access Against Reimbursement Off-label prescribing in oncology is undergoing a change: Payers are more restrictive in their reimbursement for off-label uses, while oncologists are keen to provide access to new immunotherapies.
  • 5 Tough New Ethical Dilemmas for Doctors Some ethical dilemmas that physicians deal with in their practice have been around for many years, but new ones have arisen, revolving around technology and business practices.


Medicaments pour augmenter le potentiel